HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
MCNO regimen
a chemotherapy regimen consisting of above cpds; for treatment of either metastatic or locally advanced transitional cell carcinoma of the bladder
Also Known As:
MCNO protocol
Networked:
1
relevant articles (
1
outcomes,
0
trials/studies)
Relationship Network
Therapy Context: Research Results
Therapeutics: 1158551
Drug Therapy: 293145
Combination Drug Therapy: 12066
Antineoplastic Combined Chemotherapy Protocols: 35
MCNO regimen: 1
Antineoplastic Protocols: 55
Antineoplastic Combined Chemotherapy Protocols: 35
MCNO regimen: 1
Clinical Protocols
Antineoplastic Protocols: 55
Antineoplastic Combined Chemotherapy Protocols: 35
MCNO regimen: 1
Heterocyclic Compounds: 198
Alkaloids: 5398
Indole Alkaloids: 200
Secologanin Tryptamine Alkaloids: 81
Vinca Alkaloids: 463
Vincristine: 9251
MCNO regimen: 1
Fused-Ring Heterocyclic Compounds
2-Ring Heterocyclic Compounds
Indoles: 200
Indole Alkaloids: 200
Secologanin Tryptamine Alkaloids: 81
Vinca Alkaloids: 463
Vincristine: 9251
MCNO regimen: 1
Pteridines: 147
Pterins: 160
Aminopterin: 248
Methotrexate: 24010
MCNO regimen: 1
Indolizines: 3
Indolizidines: 2
Indole Alkaloids: 200
Secologanin Tryptamine Alkaloids: 81
Vinca Alkaloids: 463
Vincristine: 9251
MCNO regimen: 1
Organic Chemicals: 133
Hydrocarbons: 1713
Cyclic Hydrocarbons: 97
Aromatic Hydrocarbons: 291
Polycyclic Aromatic Hydrocarbons: 2020
Anthracenes: 12
Anthrones: 12
Anthraquinones: 788
Mitoxantrone: 2907
MCNO regimen: 1
Coordination Complexes: 576
Carboplatin: 10368
MCNO regimen: 1
Quinones: 434
Anthraquinones: 788
Mitoxantrone: 2907
MCNO regimen: 1
Polycyclic Compounds: 6
Polycyclic Aromatic Hydrocarbons: 2020
Anthracenes: 12
Anthrones: 12
Anthraquinones: 788
Mitoxantrone: 2907
MCNO regimen: 1
Related Diseases
1.
Neoplasms (Cancer)
03/01/1998 - "
The MCNO regimen appears to have a lower efficacy than that obtained with cisplatin-based regimens for the treatment of metastatic disease and rather similar efficacy for the treatment of locally advanced urothelial-cell cancer.
"
2.
Transitional Cell Carcinoma
03/01/1998 - "
Forty-four patients with either metastatic or locally advanced transitional cell carcinoma of the bladder were treated with the MCNO regimen (methotrexate 300 mg/m2 in 1,000 ml normal saline as a 4-hour infusion on days 1 and 14 with leucovorin rescue 15 mg 6-hourly for 6 doses; carboplatin 300 mg/m2 in 250 ml 5% distilled water as a 1-hour infusion on day 1; mitoxantrone (Novantrone) 10 mg/m2 in 100 ml 5% distilled water as a 30-min infusion on day 1, and vincristine (Oncovin) 1 mg/m2 as an intravenous bolus on days 1 and 14.
"
Related Drugs and Biologics
1.
Cisplatin (Platino)
2.
Carboplatin (JM8)
3.
Vincristine (Oncovin)
4.
Mitoxantrone (Novantrone)
5.
Methotrexate (Mexate)
6.
Leucovorin (Folinic Acid)
7.
Saline Solution